Notice of Closed Meeting, 4323-4324 [2020-01208]

Download as PDF lotter on DSKBCFDHB2PROD with NOTICES Federal Register / Vol. 85, No. 16 / Friday, January 24, 2020 / Notices Financial Corporation and thereby indirectly acquire voting shares of United Bank of Michigan, both of Grand Rapids, Michigan. B. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001: 1. The John G. Paterson and Ann P. Paterson Living Trust, John G. Patterson and Ann P. Paterson as co-trustees, all of San Ramon, California; Sharon P. McGuire, Boise, Idaho; Lawrence N. Paterson, Fremont, California; Thomas G. Paterson, San Francisco, California; and Janice L. Selvy, San Carlos, California; as members of the Paterson Family Group to retain voting shares of Bethany Bankshares, Inc. and thereby indirectly retain voting shares of BTC Bank, both of Bethany, Missouri. C. Federal Reserve Bank of Minneapolis (Chris P. Wangen, Assistant Vice President), 90 Hennepin Avenue, Minneapolis, Minnesota 55480–0291: 1. Kelly A. Skalicky, New York, New York; the Norman C. Skalicky 2019 Revocable Trust, St. Cloud, Minnesota, Kelly A. Skalicky and Norman C. Skalicky, St. Cloud, Minnesota, as cotrustees; the Kelly A. Skalicky 2019 GRAT, New York, New York, Kelly A. Skalicky, trustee; and the 2019 Skalicky Family Gift Trust FBO Trenton Dean Skalicky, New York, New York, Kelly A. Skalicky, trustee; to acquire voting shares of Stearns Financial Services, Inc., St. Cloud, Minnesota, and thereby indirectly acquire voting shares of Stearns Bank NA, St. Cloud, Minnesota; Stearns Bank Holdingford NA, Holdingford, Minnesota; and Stearns Bank NA, Upsala, Minnesota. In addition, Cheryl R. Ryan, Elk River, Minnesota; Jeffery Dean Skalicky, Rosholt, South Dakota; the Cheryl R. Ryan 2019 GRAT, Elk River, Minnesota, Cheryl R. Ryan, trustee; the Jeffery D. Skalicky 2019 GRAT, Jeffery Dean Skalicky, trustee; Jan M. Hanson, Duvall, Washington; Johanna A. Ryan, Brooklyn, New York; and the 2012 Gift Trust FBO Barrett Chelsea Skalicky Doss, Barrett C. Skalicky Doss, trustee, both of Brooklyn, New York; to retain voting shares of Stearns Financial Services, Inc., and thereby indirectly retain voting shares of Stearns Bank NA, Stearns Bank Holdingford NA, and Stearns Bank NA, Upsala, Minnesota. FEDERAL RESERVE SYSTEM Formations of, Acquisitions by, and Mergers of Bank Holding Companies The companies listed in this notice have applied to the Board for approval, pursuant to the Bank Holding Company Act of 1956 (12 U.S.C. 1841 et seq.) (BHC Act), Regulation Y (12 CFR part 225), and all other applicable statutes and regulations to become a bank holding company and/or to acquire the assets or the ownership of, control of, or the power to vote shares of a bank or bank holding company and all of the banks and nonbanking companies owned by the bank holding company, including the companies listed below. The applications listed below, as well as other related filings required by the Board, if any, are available for immediate inspection at the Federal Reserve Bank indicated. The applications will also be available for inspection at the offices of the Board of Governors. Interested persons may express their views in writing on the standards enumerated in the BHC Act (12 U.S.C. 1842(c)). Comments regarding each of these applications must be received at the Reserve Bank indicated or the offices of the Board of Governors, Ann E. Misback, Secretary of the Board, 20th Street and Constitution Avenue NW, Washington, DC 20551–0001, not later than February 21, 2020. A. Federal Reserve Bank of Kansas City (Dennis Denney, Assistant Vice President) 1 Memorial Drive, Kansas City, Missouri 64198–0001: 1. HYS Investments, LLC, Topeka, Kansas; to acquire additional shares, and thereby increase their ownership from 26.02 percent to 28.55 percent, of BOTS, Inc. parent holding company of VisionBank, both of Topeka, Kansas. Board of Governors of the Federal Reserve System, January 17, 2020. Yao-Chin Chao Assistant Secretary of the Board. BILLING CODE P Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—DP20–001, Assessing the Burden of Diabetes By Type in Children, Adolescents and Young Adults (DiCAYA); Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)—DP20– 001, Assessing the Burden of Diabetes By Type in Children, Adolescents and Young Adults (DiCAYA); March 11, 2019, 10:00 a.m.–6:00 p.m., EDT. Teleconference, Centers for Disease Control and Prevention, Atlanta, Georgia 30341 which was published in the Federal Register on January 10, 2020, Volume 85, Number 7, page 1315. The meeting is being amended to change the meeting date to March 10– 11, 2020, from 11:00 a.m.–5:00 p.m., EDT, on March 10, 2020, and 10:00 a.m.–6:00 p.m., EDT, on March 11, 2020. Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341; Telephone: (770) 488–6511; kva5@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. FOR FURTHER INFORMATION CONTACT: Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–01206 Filed 1–23–20; 8:45 am] BILLING CODE 4163–18–P Centers for Disease Control and Prevention Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. BILLING CODE P Jkt 250001 Centers for Disease Control and Prevention DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2020–01123 Filed 1–23–20; 8:45 am] 17:03 Jan 23, 2020 DEPARTMENT OF HEALTH AND HUMAN SERVICES [FR Doc. 2020–01122 Filed 1–23–20; 8:45 am] Board of Governors of the Federal Reserve System, January 17, 2020. Yao-Chin Chao, Assistant Secretary of the Board. VerDate Sep<11>2014 4323 PO 00000 Frm 00055 Fmt 4703 Sfmt 4703 E:\FR\FM\24JAN1.SGM 24JAN1 4324 Federal Register / Vol. 85, No. 16 / Friday, January 24, 2020 / Notices The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)SIP20–002, Improving Cognitive Impairment Detection and Referral to Resources among Older Adults: Applying the KAER Model to Primary Care within a Health Care System. Date: April 16, 2020. Time: 11:00 a.m.–6:00 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. For Further Information Contact: Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488–6511, kva5@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. [FR Doc. 2020–01208 Filed 1–23–20; 8:45 am] lotter on DSKBCFDHB2PROD with NOTICES BILLING CODE 4163–18–P [Document Identifier: CMS–10463] Centers for Disease Control and Prevention Agency Information Collection Activities: Submission for OMB Review; Comment Request Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended, notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the Jkt 250001 [FR Doc. 2020–01207 Filed 1–23–20; 8:45 am] Centers for Medicare & Medicaid Services DEPARTMENT OF HEALTH AND HUMAN SERVICES 17:03 Jan 23, 2020 Kalwant Smagh, Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention. DEPARTMENT OF HEALTH AND HUMAN SERVICES BILLING CODE 4163–18–P VerDate Sep<11>2014 provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended, and the Determination of the Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, CDC, pursuant to Public Law 92–463. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP)— SIP20–001, Developing and Evaluating Adolescent, Parent, and Provider Resources to Improve Adolescent Use of Sexual Health Services. Date: April 14, 2020. Time: 11:00 a.m.–6:00 p.m., EDT. Place: Teleconference. Agenda: To review and evaluate grant applications. FOR FURTHER INFORMATION CONTACT: Jaya Raman Ph.D., Scientific Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, Georgia 30341, Telephone: (770) 488–6511, kva5@cdc.gov. The Director, Strategic Business Initiatives Unit, Office of the Chief Operating Officer, Centers for Disease Control and Prevention, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities, for both the Centers for Disease Control and Prevention and the Agency for Toxic Substances and Disease Registry. Centers for Medicare & Medicaid Services, HHS. ACTION: Notice. AGENCY: The Centers for Medicare & Medicaid Services (CMS) is announcing SUMMARY: PO 00000 Frm 00056 Fmt 4703 Sfmt 4703 an opportunity for the public to comment on CMS’ intention to collect information from the public. Under the Paperwork Reduction Act of 1995 (PRA), federal agencies are required to publish notice in the Federal Register concerning each proposed collection of information, including each proposed extension or reinstatement of an existing collection of information, and to allow a second opportunity for public comment on the notice. Interested persons are invited to send comments regarding the burden estimate or any other aspect of this collection of information, including the necessity and utility of the proposed information collection for the proper performance of the agency’s functions, the accuracy of the estimated burden, ways to enhance the quality, utility, and clarity of the information to be collected, and the use of automated collection techniques or other forms of information technology to minimize the information collection burden. DATES: Comments on the collection(s) of information must be received by the OMB desk officer by February 24, 2020. ADDRESSES: When commenting on the proposed information collections, please reference the document identifier or OMB control number. To be assured consideration, comments and recommendations must be received by the OMB desk officer via one of the following transmissions: OMB, Office of Information and Regulatory Affairs, Attention: CMS Desk Officer, Fax Number: (202) 395–5806, OR, Email: OIRA_submission@omb.eop.gov. To obtain copies of a supporting statement and any related forms for the proposed collection(s) summarized in this notice, you may make your request using one of following: 1. Access CMS’ website address at website address at https://www.cms.gov/ Regulations-and-Guidance/Legislation/ PaperworkReductionActof1995/PRAListing.html. 1. Email your request, including your address, phone number, OMB number, and CMS document identifier, to Paperwork@cms.hhs.gov. 2. Call the Reports Clearance Office at (410) 786–1326. FOR FURTHER INFORMATION CONTACT: William Parham at (410) 786–4669. SUPPLEMENTARY INFORMATION: Under the Paperwork Reduction Act of 1995 (PRA) (44 U.S.C. 3501–3520), federal agencies must obtain approval from the Office of Management and Budget (OMB) for each collection of information they conduct or sponsor. The term ‘‘collection of information’’ is defined in 44 U.S.C. 3502(3) and 5 CFR 1320.3(c) and E:\FR\FM\24JAN1.SGM 24JAN1

Agencies

[Federal Register Volume 85, Number 16 (Friday, January 24, 2020)]
[Notices]
[Pages 4323-4324]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-01208]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Notice of Closed Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended, notice is hereby given of the following meeting.

[[Page 4324]]

    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended, and the Determination of the Director, Strategic 
Business Initiatives Unit, Office of the Chief Operating Officer, CDC, 
pursuant to Public Law 92-463. The grant applications and the 
discussions could disclose confidential trade secrets or commercial 
property such as patentable material, and personal information 
concerning individuals associated with the grant applications, the 
disclosure of which would constitute a clearly unwarranted invasion of 
personal privacy.
    Name of Committee: Disease, Disability, and Injury Prevention and 
Control Special Emphasis Panel (SEP)- SIP20-002, Improving Cognitive 
Impairment Detection and Referral to Resources among Older Adults: 
Applying the KAER Model to Primary Care within a Health Care System.
    Date: April 16, 2020.
    Time: 11:00 a.m.-6:00 p.m., EDT.
    Place: Teleconference.
    Agenda: To review and evaluate grant applications.
    For Further Information Contact: Jaya Raman Ph.D., Scientific 
Review Officer, CDC, 4770 Buford Highway, Mailstop F80, Atlanta, 
Georgia 30341, Telephone: (770) 488-6511, [email protected].
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-01208 Filed 1-23-20; 8:45 am]
 BILLING CODE 4163-18-P